![](/img/cover-not-exists.png)
Cardiovascular risk factors and diseases precede oral hypoglycaemic therapy in patients with type 2 diabetes mellitus
Joëlle A. Erkens, Ron M.C. Herings, Ronald P. Stolk, José A. Spoelstra, Diederick E. Grobbee, Hubert G.M. LeufkensVolume:
55
Year:
2002
Language:
english
DOI:
10.1016/s0895-4356(01)00482-6
File:
PDF, 79 KB
english, 2002